EP1243266A1 — Solid preparations for oral use
Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2002-09-25 · 24y expired
What this patent protects
The purpose of invention is to provide a solid preparation for oral use that is uniform in the content and easy to take quantitatively to facilitate the application of low dosage KRP-297, being a common ligand against PPAR α and PPAR γ of peroxisome proliferant-activating recepto…
USPTO Abstract
The purpose of invention is to provide a solid preparation for oral use that is uniform in the content and easy to take quantitatively to facilitate the application of low dosage KRP-297, being a common ligand against PPAR α and PPAR γ of peroxisome proliferant-activating receptors that are intranuclear receptors, and having an improving action on the insulin resistance. By preparing a solid preparation for oral use a small amount of active ingredient and drug-making carriers, a tablet that is uniform in the content and capable of taking quantitatively and easily has been provided.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.